Chinese Drugmakers Make GMP Import Alert, Refusal to Inspect Lists

Drug Industry Daily
A A
The list of Chinese pharmaceutical companies in the FDA’s crosshairs keeps on growing, with the agency hitting two drugmakers for GMP violations and another for refusing an inspection.

To View This Article:

Login

Subscribe To Drug Industry Daily